Figure 1. A microscopic section shows an exuberant villous proliferation (hematoxylin-eosin, original magnification ×55).
Figure 2. Each villous section is lined by synovial cells with complete replacement of the subsynovial tissue by mature fat cells (hematoxylin-eosin, original magnification ×140).
Figure 3. At higher magnification there is hyperplasia of the synovial cells forming small nodules beneath the synovial lining (hematoxylin-eosin, original magnification ×280).
Villous lipomatous proliferation of the synovial membrane is a rare condition that usually occurs in the knee,1- 3 although it has been reported in other joints such as the wrist and ankle.4- 5 The disease has been reported to be developmental, traumatic, inflammatory, or neoplastic in origin4- 7 but its true cause remains unknown. This disorder is characterized by a slow painless swelling of the knee over many years with intermittent effusion. Laboratory test results, including erythrocyte sedementation rate and serological tests for rheumatoid factor and blood uric acids, are all normal. Joint aspiration is negative for crystals and cells and the cultures (aerobic, anerobic, and tubercular) are sterile. Pathologically, the condition is characterized by marked villous proliferation of the synovial membrane. There is mild hyperplasia of the synovial lining cells and complete replacement of the subsynovial tissue by mature fat cells that extend into the proliferative villous projections. Long-standing synovial thickening and effusions, which are probably caused by repeated mechanical injury to the proliferated villi, eventually lead to osteoarthritis. It has been reported in detail in 5 isolated case reports3- 4,6,8- 9 and in 1 series of 5 cases.10 The 5 cases of Hallel et al10 had a mean age of 56 years (age range, 39-66 years) and were all male. The duration of symptoms ranged from 5 to 25 years and the knee was the site of involvement for all. The severity of osteoarthritic changes in the knee correlated with the duration of the synovial disease. Synovectomy was done in all cases and 4 cases were followed up for 3, 8, 10, and 11 years. There was no recurrence of synovial thickening or effusion.
The differential diagnosis for villous synovial lipomatosis should encompass all conditions that cause painless effusion and synovial thickening without systemic involvement. These are synovial chondromatosis, pigmented villonodular synovitis, and synovial hemangiomatosis. The microscopic and macroscopic findings of these conditions are typical and, together with the clinical characteristics, should facilitate an accurate diagnosis.
This condition has been reported as lipoma arborescens; however, this term is misleading because lipoma implies a tumorous etiology. Hallel et al10 in their 5 cases have used the term villous lipomatous proliferation of the synovial membrane. We suggest synovial lipomatosis for this rare condition.
Accepted for publication August 24, 1998.
Reprints: R. K. Vasishta, MD, MRCPath, Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.